|
Significant Credit Concentrations (Tables)
|
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2013
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Significant Credit Concentrations (Tables) [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Maximum credit exposure by category | The following table details the Company's maximum credit exposure by category, including the credit exposure associated with derivative financial instruments, as of December 31:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Card Member loans and receivables exposure | The following table details the Company's Card Member loans and receivables exposure (including unused lines-of-credit on Card Member loans) in the U.S. and outside the U.S. as of December 31:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||